Memory Chip Stocks Rally Amid Mixed Market Trends

This week, memory chip stocks have experienced significant gains, but there’s a chance that some of these winners might soon see declines. The surge was largely driven by artificial intelligence trading. The S&P 500 increased by over 2%, and the tech-heavy Nasdaq Composite Index jumped nearly 4%. In contrast, the Dow Jones Industrial Average, which comprises many traditional companies, saw only a modest rise.

Among the biggest beneficiaries were semiconductor memory chip and data storage stocks, particularly the Round Hill Memory ETF (DRAM), which surged nearly 30% for the week. The increase came after the release of first-quarter results, which highlighted supply chain bottlenecks in memory chips amidst burgeoning demand. However, this rally has left some stocks appearing overbought—an assessment made when a stock’s relative strength index (RSI) exceeds 70. On the flip side, stocks with an RSI below 30 are deemed oversold and could rebound.

Focusing on the S&P 500, memory stocks dominated the overbought category, with companies like Qualcomm and Micron Technology standing out. Qualcomm experienced a remarkable increase of over 23% this week, while Micron soared nearly 37%, marking its best weekly performance since 2008. Although Qualcomm’s RSI reached a high of 86, analysts generally rate it as “Unchanged.” Predictions suggest a potential 22% drop to meet the analysts’ consensus price target. Micron, with an RSI of 82, is rated as a buy by most analysts, although its rapidly rising stock price sits 23% above the average target anticipated by analysts.

On the other hand, among the most oversold stocks was EPAM Systems, a software engineering firm, which reported an RSI of 18 after a drop of more than 11% this week. Its decline followed a downward revision of its full-year sales growth forecast, now projected at 4-6.5%, down from an earlier range of 4.5-7.5%. Analysts also have a buy consensus for EPAM, predicting a potential rise of nearly 70% to hit the consensus price target.

Additionally, Zoetis, a company specializing in animal drugs, is also in the oversold category. Its stock plummeted over 27% this week, placing its RSI close to 15. This decline came after the company disclosed first-quarter adjusted earnings that fell short of expectations, along with lowered profit and sales forecasts for the year. Should stocks rise to meet the average price targets set by analysts, those rated as “buy” could see an increase of about 75%.